Of note, TRPM2 expression is significantly enhanced during NAFLD, and its activation by ROS overproduced during the disease plays a significant role in pathophysiology contributing to its progression [333]. Here, TRPM2 is linked to metabolic dysfunction-associated steatotic liver disease.